What's New
Clinical Trial in Adolescents with Fragile X
The Murdoch Childrens Research Institute is participating in a clinical trial testing a new treatment for Fragile X syndrome in adolescents. The treatment is a capsule and the medication is taken twice daily for up to 16 weeks. To be eligible to participate in the trial, patients must fit the following criteria: Be aged 12-17 [...]
Home
The Fragile X Alliance Inc
The Fragile X Alliance Inc is a non-profit organisation whose mission statement is to promote education and research into fragile X syndrome, as well as disseminate information and new findings about fragile X syndrome.
Specifically, FXA Inc offer clinical services and educational resources. In addition to this, we are strongly involved in research projects aimed at improving care and understanding of FXS.
More information about us
Fragile X Associated Disorders
Fragile X Associated disorders are a family of three conditions:
- Fragile X Syndrome (FXS) is a genetic disorder caused by a mutation (a change in the DNA structure) in the X chromosome. It is the most common known cause of inherited developmental disability worldwide. One in 3,600 males and one in 4-6,000 females are affected. One in 150 females carry the premutation and will pass the gene on to 50% of their offspring, male or female, any of whom may be affected.
- Fragile X-associated tremor/ataxia syndrome (FXTAS), a condition which affects balance, tremor and memory in some older male gene carriers.
- Fragile X-associated primary ovarian insufficiency (FXPOI), a problem with ovarian function which can lead to infertility and early menopause in some female gene carriers.
